首页 > 最新文献

Journal of Research in Pharmacy最新文献

英文 中文
PLANT PHENOLICS AND THEIR SYNTHETIC DERIVATIVES AS INHIBITORS OF HELICOBACTER PYLORI: SUGGESTION FOR A NEW MECHANISM OF ACTION 植物酚类物质及其合成衍生物作为幽门螺杆菌抑制剂:一种新的作用机制的建议
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.388
Simone Carradori
{"title":"PLANT PHENOLICS AND THEIR SYNTHETIC DERIVATIVES AS INHIBITORS OF HELICOBACTER PYLORI: SUGGESTION FOR A NEW MECHANISM OF ACTION","authors":"Simone Carradori","doi":"10.29228/jrp.388","DOIUrl":"https://doi.org/10.29228/jrp.388","url":null,"abstract":"","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69838607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient experience in community pharmacies from an experiential marketing perspective: structural equation model 体验营销视角下的社区药房患者体验:结构方程模型
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.391
Demet AKALGAN AKLAR, G. Ozcelikay
: The main objective of this study was to model patient experience (PX) in community pharmacies as experimental marketing parameters via structural equation modeling (SEM). Our findings show that peace of mind, trust, pharmacy, customer engagement, interaction quality with the pharmacist and personnel, and atmosphere or periphery experience quality is the important component for a patient to re-visit the same pharmacy. The patient's journey to the pharmacy starts before entering the pharmacy, continues at the pharmacy, and then leaves the pharmacy. It is important to understand the touchpoint of the patient journey at a community pharmacy and the needs of the patients as well as other health services. Overall, whether it is patient experience or customer experience, both focus on people and understanding their needs as a service sector will add value to service quality. The research was conducted on 414 volunteer patients given informed consent and answered 73 items in Istanbul province. The data obtained from the questionnaire forms were analyzed using the IBM SPSS Statistics 23 package program. Confirmatory factor analysis (CFA) was applied using IBM SPSS AMOS 23 package program in the analysis of trust, pharmacy customer engagement (PCE), word of mouth (WoM), pharmacist interaction quality, personnel interaction quality, periphery experience quality, peace-of-mind (POM), and autobiographical memory parameters. Since the assumption of normality was not provided, the relationships among these items were calculated using Spearman's correlation coefficient. The results were evaluated at the significance level of p <0.05. Finally, a structural equation model was conducted to specify PX items.
本研究的主要目的是通过结构方程模型(SEM)将社区药房的患者体验(PX)作为实验营销参数进行建模。我们的研究结果表明,安心、信任、药房、客户参与度、与药剂师和工作人员的互动质量、氛围或周边体验质量是患者再次光顾同一家药房的重要组成部分。患者到药房的旅程在进入药房之前就开始了,在药房继续,然后离开药房。了解患者在社区药房就诊的接触点以及患者和其他卫生服务的需求是很重要的。总的来说,无论是患者体验还是客户体验,作为一个服务部门,都以人为本,了解他们的需求,这将增加服务质量的价值。该研究是在伊斯坦布尔省对414名自愿接受知情同意书的患者进行的,并回答了73个问题。使用IBM SPSS Statistics 23软件包程序对问卷表格中获得的数据进行分析。采用验证性因子分析(CFA),采用IBM SPSS AMOS 23包程序对信任、药房顾客参与(PCE)、口碑(WoM)、药师互动质量、人员互动质量、周边体验质量、安心(POM)、自传体记忆等参数进行分析。由于没有提供正态性假设,因此使用Spearman相关系数计算这些项目之间的关系。以p <0.05的显著性水平评价结果。最后,利用结构方程模型对PX项目进行细化。
{"title":"Patient experience in community pharmacies from an experiential marketing perspective: structural equation model","authors":"Demet AKALGAN AKLAR, G. Ozcelikay","doi":"10.29228/jrp.391","DOIUrl":"https://doi.org/10.29228/jrp.391","url":null,"abstract":": The main objective of this study was to model patient experience (PX) in community pharmacies as experimental marketing parameters via structural equation modeling (SEM). Our findings show that peace of mind, trust, pharmacy, customer engagement, interaction quality with the pharmacist and personnel, and atmosphere or periphery experience quality is the important component for a patient to re-visit the same pharmacy. The patient's journey to the pharmacy starts before entering the pharmacy, continues at the pharmacy, and then leaves the pharmacy. It is important to understand the touchpoint of the patient journey at a community pharmacy and the needs of the patients as well as other health services. Overall, whether it is patient experience or customer experience, both focus on people and understanding their needs as a service sector will add value to service quality. The research was conducted on 414 volunteer patients given informed consent and answered 73 items in Istanbul province. The data obtained from the questionnaire forms were analyzed using the IBM SPSS Statistics 23 package program. Confirmatory factor analysis (CFA) was applied using IBM SPSS AMOS 23 package program in the analysis of trust, pharmacy customer engagement (PCE), word of mouth (WoM), pharmacist interaction quality, personnel interaction quality, periphery experience quality, peace-of-mind (POM), and autobiographical memory parameters. Since the assumption of normality was not provided, the relationships among these items were calculated using Spearman's correlation coefficient. The results were evaluated at the significance level of p <0.05. Finally, a structural equation model was conducted to specify PX items.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69838724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biosynthesis of Magnesium Oxide Nanoparticles Using Opunita ficus-indica and Their Antifungal Effect Against Aspergillus Niger 榕树开孔菌合成氧化镁纳米颗粒及其对黑曲霉的抑菌作用
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.408
Taif Alholy, Walid Khaddam
: Magnesium oxide nanoparticles (MgO-NPs) were synthesis via green method using Opunita ficus indica extract as reducing and covering agent. The optimal formula for the preparation of MgO-NPs was determined by UV-Vis and DLS ( Opunita ficus -indica extracted by distilled water and ethanol solvent, magnesium nitrate salt (1mM), stirred at 70 °C for 24 h with pH= 9). UV-Vis analysis showed a peak at 300 nm, while DLS measured the hydrodynamic diameter of the nanoparticles. FTIR results suggested that the polysaccharides, phenols and amines present in the extract might have been involved in the formation of MgO-NPs from Mg (NO3)2 as the reducing agent. Image J was utilized to analyze the SEM results and determine the size, which was on average 99 nm, the shape of the nanoparticles was spherical, and EDX spectrum confirmed the presence of magnesium (Mg). It was found that MgO-NPs are highly toxic against Aspergillus niger . Which showed a gradual inhibitory effect when using the concentration of 0.5% and 1.25%, and the inhibitory ability was 66.6%, 100% respectively, when using the poisoned food technique.
:以无花果树提取物为还原剂和覆盖剂,采用绿色法合成氧化镁纳米颗粒。通过UV-Vis和DLS(用蒸馏水和乙醇溶剂硝酸镁盐(1mM)提取无花果Opunita ficus -indica,在70°C搅拌24 h, pH= 9)确定了MgO-NPs的最佳制备配方。UV-Vis分析在300 nm处出现峰值,DLS测量纳米颗粒的水动力直径。FTIR结果表明,提取物中的多糖、酚类和胺类物质可能参与了还原剂Mg (NO3)2生成MgO-NPs的过程。利用图像J对SEM结果进行分析,确定了纳米颗粒的尺寸,平均为99 nm,形状为球形,EDX光谱证实了镁(Mg)的存在。结果表明,MgO-NPs对黑曲霉具有很强的毒性。在浓度为0.5%和1.25%时表现出逐渐抑制的效果,在毒食法下的抑制能力分别为66.6%和100%。
{"title":"Biosynthesis of Magnesium Oxide Nanoparticles Using Opunita ficus-indica and Their Antifungal Effect Against Aspergillus Niger","authors":"Taif Alholy, Walid Khaddam","doi":"10.29228/jrp.408","DOIUrl":"https://doi.org/10.29228/jrp.408","url":null,"abstract":": Magnesium oxide nanoparticles (MgO-NPs) were synthesis via green method using Opunita ficus indica extract as reducing and covering agent. The optimal formula for the preparation of MgO-NPs was determined by UV-Vis and DLS ( Opunita ficus -indica extracted by distilled water and ethanol solvent, magnesium nitrate salt (1mM), stirred at 70 °C for 24 h with pH= 9). UV-Vis analysis showed a peak at 300 nm, while DLS measured the hydrodynamic diameter of the nanoparticles. FTIR results suggested that the polysaccharides, phenols and amines present in the extract might have been involved in the formation of MgO-NPs from Mg (NO3)2 as the reducing agent. Image J was utilized to analyze the SEM results and determine the size, which was on average 99 nm, the shape of the nanoparticles was spherical, and EDX spectrum confirmed the presence of magnesium (Mg). It was found that MgO-NPs are highly toxic against Aspergillus niger . Which showed a gradual inhibitory effect when using the concentration of 0.5% and 1.25%, and the inhibitory ability was 66.6%, 100% respectively, when using the poisoned food technique.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"25 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69838789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
R&D STUDIES IN THE DEVELOPMENT OF TRADITIONAL HERBAL MEDICINAL PRODUCTS 传统草药产品开发的研发研究
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.379
Iffet Irem TATLI ÇANKAYA
{"title":"R&D STUDIES IN THE DEVELOPMENT OF TRADITIONAL HERBAL MEDICINAL PRODUCTS","authors":"Iffet Irem TATLI ÇANKAYA","doi":"10.29228/jrp.379","DOIUrl":"https://doi.org/10.29228/jrp.379","url":null,"abstract":"","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69838884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Nutraceutical Potential, in vitro Antioxidant and Free Radical Scavenging Activity of Indian Royal Jelly 印度蜂王浆的营养潜力、体外抗氧化和自由基清除活性研究
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.417
R. Dubey, L. Sathiyanarayanan, Laxmi Rao, S. Sankaran
: Apis mellifera , a priceless bee species is known to produce various nutritional products. Royal Jelly (RJ) is one such bee product which has high nutritive value, functional and biological qualities. However factors such as bee species, environment, season, collection technique and larval age affect the composition of RJ at macro and micro levels thus there is a need to evaluate Indian Royal Jelly (IRJ) for its chemical properties. So in the present work IRJ samples collected from Southern, Central and Northern regions of India were evaluated for physicochemical parameters (nature, color, appearance, odor, and solubility,) residual content (moisture content, ash value and pesticide content), chemical attributes (total polyphenol content, total flavonoid content,), nutraceutical potential (total fat, protein, carbohydrate content, and energy), and antioxidant activity (DPPH assay, ABTS assay and reducing power,). The total flavonoid content and total phenolic content were in the range of 0.119-0.321 mg quercetin/g of IRJ and 25.2844-68.203 mg Gallic acid/g, respectively. High energy, protein and low fat value suggested IRJ as a suitable nutraceutical agent. Antioxidant activity (IC 50 ) of IRJ samples was found to be in the order of IRJ II > IRJ IV > IRJ I > IRJ III. Overall, it was observed that the IRJ-II showed better nutritional efficacy, polyphenolic content, and antioxidant properties.
蜜蜂是一种无价的蜜蜂,它能生产各种营养产品。蜂王浆(RJ)是一种具有较高营养价值、功能性和生物学品质的蜂产品。然而,蜜蜂种类、环境、季节、采集技术和幼虫年龄等因素对蜂王浆的组成有宏观和微观的影响,因此有必要对印度蜂王浆(IRJ)的化学性质进行评价。因此,在本工作中,从印度南部、中部和北部地区收集的IRJ样品进行了理化参数(性质、颜色、外观、气味和溶解度)、残留量(水分含量、灰分值和农药含量)、化学属性(总多酚含量、总黄酮含量)、营养潜力(总脂肪、蛋白质、碳水化合物含量和能量)和抗氧化活性(DPPH测定、ABTS测定和还原力)的评估。IRJ的总黄酮含量为0.119 ~ 0.321 mg槲皮素/g,总酚含量为25.2844 ~ 68.203 mg没食子酸/g。高能量、高蛋白质、低脂肪的营养价值表明IRJ是一种合适的营养保健剂。IRJ样品的抗氧化活性(IC 50)依次为IRJ II > IRJ IV > IRJ I > IRJ III。总体而言,IRJ-II具有更好的营养功效、多酚含量和抗氧化性能。
{"title":"Investigation of Nutraceutical Potential, in vitro Antioxidant and Free Radical Scavenging Activity of Indian Royal Jelly","authors":"R. Dubey, L. Sathiyanarayanan, Laxmi Rao, S. Sankaran","doi":"10.29228/jrp.417","DOIUrl":"https://doi.org/10.29228/jrp.417","url":null,"abstract":": Apis mellifera , a priceless bee species is known to produce various nutritional products. Royal Jelly (RJ) is one such bee product which has high nutritive value, functional and biological qualities. However factors such as bee species, environment, season, collection technique and larval age affect the composition of RJ at macro and micro levels thus there is a need to evaluate Indian Royal Jelly (IRJ) for its chemical properties. So in the present work IRJ samples collected from Southern, Central and Northern regions of India were evaluated for physicochemical parameters (nature, color, appearance, odor, and solubility,) residual content (moisture content, ash value and pesticide content), chemical attributes (total polyphenol content, total flavonoid content,), nutraceutical potential (total fat, protein, carbohydrate content, and energy), and antioxidant activity (DPPH assay, ABTS assay and reducing power,). The total flavonoid content and total phenolic content were in the range of 0.119-0.321 mg quercetin/g of IRJ and 25.2844-68.203 mg Gallic acid/g, respectively. High energy, protein and low fat value suggested IRJ as a suitable nutraceutical agent. Antioxidant activity (IC 50 ) of IRJ samples was found to be in the order of IRJ II > IRJ IV > IRJ I > IRJ III. Overall, it was observed that the IRJ-II showed better nutritional efficacy, polyphenolic content, and antioxidant properties.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response surface methodology-aided maceration method optimization of quercetin-standardized purified extract of shallot skin (Allium cepa L var. aggregatum) 响应面法辅助浸渍法优化槲皮素标准纯化葱皮提取物
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.428
Sapri Sapri, F. Riswanto, E. Wulandari
: Shallot skin has potential as a medicinal raw material because it contains many quercetin compounds. It is necessary to conduct a study on the optimization of extraction methods and the extracts standardization. The purpose of this study is the standardization of simplicia, optimization of extraction methods and standardization of shallot skin purified extract as standardized on quercetin. This study is aimed to support quality control of simplicia and shallot skin extract as a source of quercetin. The methods of the study include the collection of raw materials, preparation of simplicia, standardization of simplicia, and optimization of extraction methods with Response Surface Methodology (RSM) using Box-Behnken Design (BBD), standardization of standardized quercetin purified extracts. Based on the results obtained, shallot skin simplicia has a moisture content of 7.98 and a total ash content of 9.91%. Based on the analysis, the optimum point of the solvent concentration factor, time, and the solvent ratio on the yield of the purified extract were respectively 60.42%, 1.29 hours, and 24.45 mL/g. The yield average obtained was 5.16 ± 0.1125 % with a content of 5.947 ppm (0.005497 mg/g).
由于含有许多槲皮素化合物,葱皮有可能成为药用原料。有必要对其提取方法的优化和提取物的标准化进行研究。本研究的目的是简化方法的标准化、提取方法的优化以及以槲皮素为标准的葱皮纯化提取物的标准化。本研究旨在为槲皮素的质量控制提供依据。本研究的方法包括原料的收集、栀子的制备、栀子的标准化、Box-Behnken设计(BBD)响应面法(RSM)优化提取方法、槲皮素纯化物的标准化。结果表明,青葱皮含水量为7.98,总灰分含量为9.91%。经分析,溶剂浓度因子、时间、溶剂比对提取液得率的最佳影响点分别为60.42%、1.29 h、24.45 mL/g。平均产率为5.16±0.1125%,含量为5.947 ppm (0.005497 mg/g)。
{"title":"Response surface methodology-aided maceration method optimization of quercetin-standardized purified extract of shallot skin (Allium cepa L var. aggregatum)","authors":"Sapri Sapri, F. Riswanto, E. Wulandari","doi":"10.29228/jrp.428","DOIUrl":"https://doi.org/10.29228/jrp.428","url":null,"abstract":": Shallot skin has potential as a medicinal raw material because it contains many quercetin compounds. It is necessary to conduct a study on the optimization of extraction methods and the extracts standardization. The purpose of this study is the standardization of simplicia, optimization of extraction methods and standardization of shallot skin purified extract as standardized on quercetin. This study is aimed to support quality control of simplicia and shallot skin extract as a source of quercetin. The methods of the study include the collection of raw materials, preparation of simplicia, standardization of simplicia, and optimization of extraction methods with Response Surface Methodology (RSM) using Box-Behnken Design (BBD), standardization of standardized quercetin purified extracts. Based on the results obtained, shallot skin simplicia has a moisture content of 7.98 and a total ash content of 9.91%. Based on the analysis, the optimum point of the solvent concentration factor, time, and the solvent ratio on the yield of the purified extract were respectively 60.42%, 1.29 hours, and 24.45 mL/g. The yield average obtained was 5.16 ± 0.1125 % with a content of 5.947 ppm (0.005497 mg/g).","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Combination of DNR and Casticin show advantage in favor of apoptosis on AML leukemia stem-like cell lines? A preliminary study 在AML白血病干细胞样细胞系中,DNR和Casticin联合使用是否有促进细胞凋亡的优势?初步研究
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.416
Tuğba Erkmen, H. Ateş, A. S. Koçtürk
: Acute myeloid leukemia (AML) is a form of acute leukemia with the highest incidence and the lowest overall survival rates. Insufficiency of targeting leukemia stem cells (LSC) is the main obstacle that causes drug resistance and relapse in AML. Another important problem is chemotherapeutics’ toxicity. Developing a combination, including well-known chemotherapeutics in lower dose and new agent that have capacity to target LSC may be more reliable and practical way to overcome these limitations. Previously, we found that Casticin polyphenol induces apoptosis in AML stem-like (KG1a) and parental (KG1) cell lines without affecting healthy cell. Therefore, for the first time, we aimed to find synergistic combination of Daunorubicin (DNR) and Casticin to target apoptosis in both LSC and leukemic blasts with less toxicity. Synergism of DNR-Casticin combinations on KG1a, KG1, HL-60 cells were determined with MTT viability assay by Chou-Talalay method. The apoptotic/necrotic effects of combinations were evaluated with Annexin V- PI kit by flow cytometry. Synergistic combination of 0.25 µM DNR + 0.0625 µM Casticin (combination index, CI<1) decreased cell viability to 45.3% and 63.2% in KG1a, KG1 cell lines, respectively. However, the combination-induced apoptosis (KG1a: 5 %; KG1: 5.8%) were not higher than 0.25 µM DNR-induced (KG1a: 9.4%; KG1: 8.1%) or 0.0625 µM Casticin-induced (KG1a: 3.8%; KG1: 5.1%) apoptosis (p>0.05). Our study showed that synergistic combination of DNR-Casticin causes important decrease in cell viability. Although we did not detect increase in apoptosis with the combination, we presume that other cell death pathways may be included. The highest apoptosis was obtained by the treatment of 2 µM Casticin alone in KG1a (21.7%), KG1 (26.5%), HL-60 (14.6%). Therefore, we think that Casticin polyphenol might be the possible candidate for new targeted therapy studies for AML.
急性髓性白血病(AML)是一种发病率最高、总生存率最低的急性白血病。靶向白血病干细胞(LSC)不足是导致AML耐药和复发的主要障碍。另一个重要的问题是化疗药物的毒性。开发一种联合疗法,包括知名的低剂量化疗药物和具有靶向LSC能力的新药,可能是克服这些局限性的更可靠和实用的方法。之前,我们发现蓖麻素多酚诱导AML干细胞样(KG1a)和亲本(KG1)细胞系凋亡,而不影响健康细胞。因此,我们首次试图寻找柔红霉素(DNR)和Casticin的协同组合,在毒性较小的情况下靶向LSC和白血病母细胞的凋亡。采用cho - talalay法MTT活力测定DNR-Casticin联合用药对KG1a、KG1、HL-60细胞的增效作用。流式细胞术应用Annexin V- PI试剂盒评价联合用药对细胞凋亡/坏死的影响。0.25µM DNR + 0.0625µM Casticin协同联合(联合指数,CI0.05)。我们的研究表明,DNR-Casticin的协同组合导致细胞活力显著降低。虽然我们没有发现联合用药增加细胞凋亡,但我们推测可能包括其他细胞死亡途径。2µM Casticin单独处理KG1a(21.7%)、KG1(26.5%)和HL-60(14.6%)的细胞凋亡率最高。因此,我们认为蓖麻素多酚可能是AML新的靶向治疗研究的候选药物。
{"title":"Does Combination of DNR and Casticin show advantage in favor of apoptosis on AML leukemia stem-like cell lines? A preliminary study","authors":"Tuğba Erkmen, H. Ateş, A. S. Koçtürk","doi":"10.29228/jrp.416","DOIUrl":"https://doi.org/10.29228/jrp.416","url":null,"abstract":": Acute myeloid leukemia (AML) is a form of acute leukemia with the highest incidence and the lowest overall survival rates. Insufficiency of targeting leukemia stem cells (LSC) is the main obstacle that causes drug resistance and relapse in AML. Another important problem is chemotherapeutics’ toxicity. Developing a combination, including well-known chemotherapeutics in lower dose and new agent that have capacity to target LSC may be more reliable and practical way to overcome these limitations. Previously, we found that Casticin polyphenol induces apoptosis in AML stem-like (KG1a) and parental (KG1) cell lines without affecting healthy cell. Therefore, for the first time, we aimed to find synergistic combination of Daunorubicin (DNR) and Casticin to target apoptosis in both LSC and leukemic blasts with less toxicity. Synergism of DNR-Casticin combinations on KG1a, KG1, HL-60 cells were determined with MTT viability assay by Chou-Talalay method. The apoptotic/necrotic effects of combinations were evaluated with Annexin V- PI kit by flow cytometry. Synergistic combination of 0.25 µM DNR + 0.0625 µM Casticin (combination index, CI<1) decreased cell viability to 45.3% and 63.2% in KG1a, KG1 cell lines, respectively. However, the combination-induced apoptosis (KG1a: 5 %; KG1: 5.8%) were not higher than 0.25 µM DNR-induced (KG1a: 9.4%; KG1: 8.1%) or 0.0625 µM Casticin-induced (KG1a: 3.8%; KG1: 5.1%) apoptosis (p>0.05). Our study showed that synergistic combination of DNR-Casticin causes important decrease in cell viability. Although we did not detect increase in apoptosis with the combination, we presume that other cell death pathways may be included. The highest apoptosis was obtained by the treatment of 2 µM Casticin alone in KG1a (21.7%), KG1 (26.5%), HL-60 (14.6%). Therefore, we think that Casticin polyphenol might be the possible candidate for new targeted therapy studies for AML.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular docking and drug-likeness study of nirmatrelvir as promising drug candidates of dengue virus NS2B-NS3 protease 尼马特利韦作为登革病毒NS2B-NS3蛋白酶候选药物的分子对接及药物相似性研究
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.460
A. Moyeenul Huq, M. Roney, S. N. Tajuddin, M. Aluwi
: Aedes aegypti is the primary vector for the transmission of the dengue virus (DENV), which causes dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). There is now no antiviral medication available to treat DENV, which kills thousands of people year and infects millions of individuals. Due to the current situation, effective and useful treatments for this virus urgently need to be developed. Therefore, the goal of the current work was to determine, using molecular docking and drug-likeness analysis, the anti-viral potential of Nirmatrelvir inhibitor against DENV (1-4) NS2B-NS3 protease. Nirmatrelvir shown robust and stable bonding in the binding pocket of DENV (1-4) NS2B-NS3 protease, as demonstrated by molecular docking. According to the drug-likeness study, Nirmatrelvir shown druggability and may function as possible inhibitor to halt DENV proliferation. To establish their action and other qualities, it is also necessary to research how substances behave in both in-vitro and in-vivo settings.
:埃及伊蚊是传播登革热病毒(DENV)的主要媒介,登革热病毒可引起登革热(DF)、登革出血热(DHF)和登革休克综合征(DSS)。目前没有抗病毒药物可用于治疗DENV, DENV每年导致数千人死亡,数百万人感染。鉴于目前的情况,迫切需要开发有效和有用的治疗方法。因此,本研究的目的是通过分子对接和药物相似性分析来确定Nirmatrelvir抑制剂对DENV (1-4) NS2B-NS3蛋白酶的抗病毒潜力。通过分子对接证实,Nirmatrelvir在DENV (1-4) NS2B-NS3蛋白酶的结合口袋中表现出强大而稳定的结合。根据药物相似性研究,Nirmatrelvir显示出药物性,可能作为阻止DENV增殖的可能抑制剂。为了确定它们的作用和其他性质,还需要研究物质在体外和体内的行为。
{"title":"Molecular docking and drug-likeness study of nirmatrelvir as promising drug candidates of dengue virus NS2B-NS3 protease","authors":"A. Moyeenul Huq, M. Roney, S. N. Tajuddin, M. Aluwi","doi":"10.29228/jrp.460","DOIUrl":"https://doi.org/10.29228/jrp.460","url":null,"abstract":": Aedes aegypti is the primary vector for the transmission of the dengue virus (DENV), which causes dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). There is now no antiviral medication available to treat DENV, which kills thousands of people year and infects millions of individuals. Due to the current situation, effective and useful treatments for this virus urgently need to be developed. Therefore, the goal of the current work was to determine, using molecular docking and drug-likeness analysis, the anti-viral potential of Nirmatrelvir inhibitor against DENV (1-4) NS2B-NS3 protease. Nirmatrelvir shown robust and stable bonding in the binding pocket of DENV (1-4) NS2B-NS3 protease, as demonstrated by molecular docking. According to the drug-likeness study, Nirmatrelvir shown druggability and may function as possible inhibitor to halt DENV proliferation. To establish their action and other qualities, it is also necessary to research how substances behave in both in-vitro and in-vivo settings.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and in vitro evaluation of pramipexole orally disintegrating tablets for pediatric restless leg syndrome 普拉克索口腔崩解片治疗小儿不宁腿综合征的处方及体外评价
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.465
Ömer Türkmen, L. Pozharani, Moein Amel
: In this study, orally disintegrating tablets (ODT) of pramipexole dihydrochloride monohydrate (PPX) was developed with direct compression method by using ready-to-use excipients Parteck ® ODT, Pharmaburst ® 500, Ludiflash ® , F-Melt ® , and Prosolv ® Easytab SP for pediatric restless leg syndrome (RLS). The formulated ODTs were circular in shape with a total weight of around 100 mg, which was appropriate for pediatric use. In spite of very low content of the drug, content uniformity could be obtained successfully in accordance to the pharmacopoeial specification with a satisfactory mechanical strength in terms of hardness and friability. However, formulations based on Parteck ® ODT and Ludiflash® could not achieve a disintegration time <30 s according to in vitro disintegration test, which was also supported by the simulated wetting test. The optimal ODTs based on Pharmaburst ® 500, F-Melt ® and Prosolv ® Easytab SP were further evaluated for in vitro dissolution study. A very fast release of the drug was observed with these formulations that reached a peak value in 10 min., which was superior than that of the reference conventional tablet formulation of PPX. As a result, pediatric orally disintegrating tablets of PPX were successfully formulated with Pharmaburst ® 500, F-Melt ® and Prosolv ® Easytab SP by using direct compression method with suitable characteristics, which can be further studied to use in pediatric RLS.
本研究以Parteck®ODT、Pharmaburst®500、Ludiflash®、F-Melt®和Prosolv®Easytab SP为辅料,采用直接压缩法开发了用于儿童不宁腿综合征(RLS)的盐酸一水普拉克索口腔崩解片(PPX)。配制的odt呈圆形,总重量约为100毫克,适合儿科使用。虽然该药物的含量很低,但其含量均匀性符合药典规范要求,硬度和脆性机械强度均令人满意。然而,基于Parteck®ODT和Ludiflash®的配方在体外崩解试验中不能达到崩解时间<30 s,模拟润湿试验也支持了这一点。以pharmacurst®500、F-Melt®和Prosolv®Easytab SP为基础,进一步评价最佳ODTs体外溶出度研究。该制剂的释药速度非常快,在10 min内达到释药峰值,优于PPX的常规对照片制剂。结果,本研究成功地以Pharmaburst®500、F-Melt®和Prosolv®Easytab SP为主要成分,采用具有合适特性的直接压缩法配制了PPX小儿口腔崩解片,可进一步研究其在小儿睡眠性睡眠症中的应用。
{"title":"Formulation and in vitro evaluation of pramipexole orally disintegrating tablets for pediatric restless leg syndrome","authors":"Ömer Türkmen, L. Pozharani, Moein Amel","doi":"10.29228/jrp.465","DOIUrl":"https://doi.org/10.29228/jrp.465","url":null,"abstract":": In this study, orally disintegrating tablets (ODT) of pramipexole dihydrochloride monohydrate (PPX) was developed with direct compression method by using ready-to-use excipients Parteck ® ODT, Pharmaburst ® 500, Ludiflash ® , F-Melt ® , and Prosolv ® Easytab SP for pediatric restless leg syndrome (RLS). The formulated ODTs were circular in shape with a total weight of around 100 mg, which was appropriate for pediatric use. In spite of very low content of the drug, content uniformity could be obtained successfully in accordance to the pharmacopoeial specification with a satisfactory mechanical strength in terms of hardness and friability. However, formulations based on Parteck ® ODT and Ludiflash® could not achieve a disintegration time <30 s according to in vitro disintegration test, which was also supported by the simulated wetting test. The optimal ODTs based on Pharmaburst ® 500, F-Melt ® and Prosolv ® Easytab SP were further evaluated for in vitro dissolution study. A very fast release of the drug was observed with these formulations that reached a peak value in 10 min., which was superior than that of the reference conventional tablet formulation of PPX. As a result, pediatric orally disintegrating tablets of PPX were successfully formulated with Pharmaburst ® 500, F-Melt ® and Prosolv ® Easytab SP by using direct compression method with suitable characteristics, which can be further studied to use in pediatric RLS.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Polyelectrolyte Complex Beads Containing Vancomycin Hydrochloride for Colon-targeted Drug Delivery 用于结肠靶向给药的盐酸万古霉素聚电解质复合物微球的研制
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 DOI: 10.29228/jrp.450
Venkateswarlu Kudipudi, Ravishankar Kakarparthy, Prakash Nathaniel Kumar Sarella, V. R. Kolapalli
: Vancomycin Hydrochloride is a glycopeptide antibiotic used for the treatment of Pseudomembranous colitis. This drug is susceptible to proteolytic degradation in the gastric environment and it is associated with nephrotoxicity. As the therapeutic action of vancomycin hydrochloride is intended in the intestine, colon-targeted drug delivery could help the drug achieve sufficient concentration in the target site. A polyelectrolyte complex using chitosan and hupu gum is used to prepare the beads that control the drug release and minimize the adverse effects. Eudragit S100 is used as an enteric coating material to bypass the gastric environment. The beads thus formed by polyelectrolyte complex were filled into capsules and coated with Eudragit S100. The formulation (CHP3C8) containing chitosan and hupu gum with polyethylene glycol 400 and 8% Eudragit S100 coating has shown a controlled drug release of up to 24 hours with a predetermined lag time. The ex-vivo studies have shown higher drug release in rat cecal content which can be attributed to the degradation of polyelectrolyte complex by intestinal bacteria. The in-vivo studies are carried out using white New Zealand rabbits where the capsules (CHP3C8) and solution of pure drug of vancomycin hydrochloride are administered via the oral route. The peak plasma concentration (C max ) of Vancomycin Hydrochloride from CHP3C8 and the oral solution was found to be 809.53 µ g/ml and 402 µ g/ml respectively. All the results have shown the superiority of Vancomycin Hydrochloride polyelectrolyte beads (CHP3C8) over the pure drug indicating its suitability for colon drug delivery.
{"title":"Development of Polyelectrolyte Complex Beads Containing Vancomycin Hydrochloride for Colon-targeted Drug Delivery","authors":"Venkateswarlu Kudipudi, Ravishankar Kakarparthy, Prakash Nathaniel Kumar Sarella, V. R. Kolapalli","doi":"10.29228/jrp.450","DOIUrl":"https://doi.org/10.29228/jrp.450","url":null,"abstract":": Vancomycin Hydrochloride is a glycopeptide antibiotic used for the treatment of Pseudomembranous colitis. This drug is susceptible to proteolytic degradation in the gastric environment and it is associated with nephrotoxicity. As the therapeutic action of vancomycin hydrochloride is intended in the intestine, colon-targeted drug delivery could help the drug achieve sufficient concentration in the target site. A polyelectrolyte complex using chitosan and hupu gum is used to prepare the beads that control the drug release and minimize the adverse effects. Eudragit S100 is used as an enteric coating material to bypass the gastric environment. The beads thus formed by polyelectrolyte complex were filled into capsules and coated with Eudragit S100. The formulation (CHP3C8) containing chitosan and hupu gum with polyethylene glycol 400 and 8% Eudragit S100 coating has shown a controlled drug release of up to 24 hours with a predetermined lag time. The ex-vivo studies have shown higher drug release in rat cecal content which can be attributed to the degradation of polyelectrolyte complex by intestinal bacteria. The in-vivo studies are carried out using white New Zealand rabbits where the capsules (CHP3C8) and solution of pure drug of vancomycin hydrochloride are administered via the oral route. The peak plasma concentration (C max ) of Vancomycin Hydrochloride from CHP3C8 and the oral solution was found to be 809.53 µ g/ml and 402 µ g/ml respectively. All the results have shown the superiority of Vancomycin Hydrochloride polyelectrolyte beads (CHP3C8) over the pure drug indicating its suitability for colon drug delivery.","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69839839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1